Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 06/23/2025 3:20:56 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 620
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
16578
Hound so you see a whale?
leedom
12/16/2015 3:07:13 PM
16574
These giant trades are extremely unusual. 200k
Drano
12/16/2015 2:32:18 PM
16573
Sox Leo has the perfect opportunity for a deal
leedom
12/16/2015 1:57:47 PM
16572
I suggest you to read the latest 10-Q. Itll
sox0407
12/16/2015 1:51:07 PM
16571
Drano that stuff means nothing. We are down 5%
leedom
12/16/2015 1:46:55 PM
16570
200k trade in one minute. Here's a 1-minute
Drano
12/16/2015 1:41:29 PM
16569
In the green now on today's new stock
Drano
12/16/2015 12:55:29 PM
16568
I worked with a guy who was a type1 diabetic. He
leedom
12/16/2015 12:55:07 PM
16567
Trolls? We have $7.7mm to do all these trials.
leedom
12/16/2015 12:52:08 PM
16566
The article Dana-Farber submitted about Kevetrin
Drano
12/16/2015 12:44:35 PM
16565
The FUD claims of CTIX needing more money, having
Drano
12/16/2015 12:42:06 PM
16564
Kevetrin does have the long lasting effect of
sox0407
12/16/2015 12:41:29 PM
16561
SOX we are looking at 6+ trials in 2016. $7.7mm
leedom
12/16/2015 12:32:07 PM
16560
Dilutions have been minimal over the years. If
sox0407
12/16/2015 11:59:20 AM
16558
Theory about the U of Bologna Kevetrin trial
Drano
12/16/2015 11:56:41 AM
16554
Attention Mac users: Chrome seems to work much
Drano
12/16/2015 11:42:05 AM
16553
imaginary shares? LMAO! I love the science and
leedom
12/16/2015 11:41:23 AM
16552
All excellent points/info, doubleJ23. The
Drano
12/16/2015 11:39:26 AM
16551
According to articles, good liars try to make
Drano
12/16/2015 11:34:54 AM
16550
Also, even though Leo mentions the ABSSSI market
doubleJ23
12/16/2015 11:28:58 AM
16549
Look if you are going to pretend to own the
F1ash
12/16/2015 11:27:29 AM
16548
There must be something positive about the
sox0407
12/16/2015 11:22:16 AM
16547
Thanks again doubleJ23. I agree that they are
Drano
12/16/2015 11:20:11 AM
16546
So we are down 10% on 250,000
leedom
12/16/2015 11:18:21 AM
16545
That was posted on Yahoo...I guess my assessment
leedom
12/16/2015 11:16:32 AM
16544
Congrats to all of us here who have evidently
Drano
12/16/2015 11:14:42 AM
16543
Thanks for letting us know your other name at
Drano
12/16/2015 11:12:08 AM
16542
Believe me, it was on the tip of my tongue when
doubleJ23
12/16/2015 11:09:12 AM
16541
Thanks for your posts.
ready2rock
12/16/2015 11:06:03 AM
16540
$1.33 well apparently there must be a lot of
leedom
12/16/2015 11:02:42 AM
16539
You may have seen that Solgenix just reported
Drano
12/16/2015 10:49:51 AM
16538
Drano I'm lee122oneill over on the Y board. and
leedom
12/16/2015 10:49:50 AM
16537
That was my guess too. We knew that the bashers
Drano
12/16/2015 10:38:39 AM
16536
Please tell us what name you post under at the
Drano
12/16/2015 10:32:50 AM
16535
You can count on it that someone from the short
Drano
12/16/2015 10:30:29 AM
16534
Your last four posts are all downers. Your posts
thefamilyman
12/16/2015 10:24:36 AM
16533
Somebody keeps bidding for a lot of
grotty
12/16/2015 10:14:16 AM
16532
Science is awesome and Leo has shareholders best
AlanC
12/16/2015 10:08:08 AM
16531
He did not rule it out either. It would depend on
scgmck1
12/16/2015 10:00:37 AM
16530
I bought more at 1.44
grotty
12/16/2015 9:59:47 AM
16529
It was a great meeting and the future is bright
AlanC
12/16/2015 9:59:28 AM
16528
AlanC Science is NO GOOD if you don't have the
leedom
12/16/2015 9:58:02 AM
16527
Your reaction is exactly the reason they would
AlanC
12/16/2015 9:56:12 AM
16526
In all likelihood and Leo agrees Rosen will get a
leedom
12/16/2015 9:56:11 AM
16525
Testing
grotty
12/16/2015 9:55:05 AM
16524
$1.42 Yea great meeting!
leedom
12/16/2015 9:53:41 AM
16523
$1.47 I guess Leo saying no deal until Phase3
leedom
12/16/2015 9:45:16 AM
16522
The support for this site is growing. Similar
AlanC
12/16/2015 9:40:54 AM
16521
Drano: Think about CTIX this way: There are no
AlanC
12/16/2015 9:33:44 AM
16520
I believe it's related to safety studies for
biodoc
12/16/2015 9:28:41 AM
Newer
Older
Recent Articles
Unlocking Bitcoin's Potential: Galaxy Digital's Investment in Function
Trianz Unveils Groundbreaking Solutions at AWS Summit NYC 2025
Unlocking the Future: The Role of Trust in AI Advancement
Sobi Reports Q2 2025: Impressive Growth and Future Outlook
Sobi Reports Robust Performance in Q2 2025 Financials
Explore CJB Crypto's Innovative Green Mining Solutions
Join Tetragon Financial Group Limited for Upcoming Investor Call
Synovus Financial Earnings Expectations and Analyst Insights
Exploring Growth in the Projection Mapping Industry Through 2032
ICG Achieves Strong Growth with $123bn in Q1 Trading
Hofseth BioCare's ProGo® Triumphs at NutraIngredients Awards
IMCD Strengthens Leadership with New Executive Appointments
Nilörn Group Sees Mixed Financial Results for Q2 2025
Kenmare Resources Q2 2025 Production Update Highlights
Foresight Group's Strategic Share Buyback Initiative Explained
Caledonia Mining Reports Record Gold Production in Q2 2025
Stellantis Shifts Focus Away from Hydrogen Fuel Cell Development
Bitget Expands Token Offerings with Eclipse Listing and Rewards
Hofseth BioCare's ProGo® Earns Top Honors for Healthy Aging
Leadership Changes at IMCD to Enhance Global Operations
Kenmare Resources Reports Solid Production Results for 2025
ICG's Q1 Performance Review: Insights on Fundraising Growth
Nilörn Reports Insights from Q2 2025 Business Performance
Tetragon Financial Group: Upcoming Investor Call Insights
Xlence Unveils Trading Central Suite for Enhanced Trading Success
Innovative Global Healthcare Challenge Spotlights Emerging Startups
Elevating In-Car Entertainment: LG's webOS in New Kia Models
Experience Premium In-Car Entertainment with LG and Kia
ESET PROTECT Complete: Leaders in Cybersecurity Solutions 2025
Richemont Achieves Strong Growth in Q1 Sales Performance
Economist Peter Schiff Forecasts Market Reaction to Trump’s Tariffs
Nuwellis Achieves Significant Growth with New Patent Approval
Alm. Brand Group Reports Impressive Q2 Financial Results
Ocuco Faces Scrutiny After Massive Data Breach Affecting Patients
London Properties, Inc. Faces Scrutiny Over Data Breach
Investigation into ACCU Reference Medical Lab for Data Breach
Innovative Cybersecurity Solutions Earn Penta Recognition
ESET PROTECT Complete: The Future of Malware Protection
Promising Q2 Results: Alm. Brand Group's Solid Performance Overview
DNO ASA Temporarily Halts Operations Amidst Unexpected Incidents
Bitget Wallet Launches Weekly Staking Event with PUMP Tokens
ASML Reports Strong Q2 Performance with €7.7B in Sales
Borregaard ASA Achieves Significant Growth in 2nd Quarter
Ontex Revises 2025 Outlook Amid Falling Revenues and Margins
Aker ASA's Robust Financial Performance in 2025 Revealed
Market Watch: Inflation Raises Eyebrows as Fed Adjustments Loom
Argo Appoints Wilbert Landry to Boost Board Strength
ASML's Impressive Q2 Results Showcase Strong Growth Outlook
Sanofi's Innovative Gene Therapy Receives Fast Track Status
Ontex's Q1 Report: Navigating Market Challenges with Resilience